Acalabrutinib with or without obinutuzumab versus chlorambucil and obinutuzumab for treatment-naive chronic lymphocytic leukaemia (ELEVATE-TN): a randomised, controlled, phase 3 trial
Willamette Valley Cancer Institute and Research Center · Somogy Megyei Kaposi Mór Oktató Kórház · +29 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
601
total citations
- FWCI
- 49.78
- Percentile
- 100%
- References
- 30
Citations per year
Authors
29Topics & keywords
Topics
Keywords
- Obinutuzumab
- Chlorambucil
- Medicine
- Chronic lymphocytic leukemia
- Internal medicine
- Gastroenterology
- Oncology
- Leukemia
No related works found for this paper.